Coronavirus vaccines can significantly reduce the risk of heart failure and blood clots after contracting the coronavirus, according to research published in the British Medical Journal.

In this study, health Data on 10.17 million people in three European countries who have been vaccinated with Moderna, Pfizer, AstraZeneca and Johnson & Johnson vaccines, and 10.39 million who have not been vaccinated.

This study shows that COVID-19 vaccination significantly reduces the risk of heart disease and thromboembolism following COVID-19 infection during the first 30 days and consistently reduces disease for up to a year thereafter. There was found.

“What we show in this very large study is that vaccinated people have a significantly reduced risk of these complications after contracting COVID-19,” said the University of Oxford. said Daniel Prieto-Alhambra, professor of pharmacoepidemiology and instrumental epidemiology. Senior author of this study.

Researchers said the vaccine reduced the risk of blood clots in veins by 78%, blood clots in arteries by 47% and heart failure by 55% within one month of administration.

The study found that the coronavirus vaccine reduced the risk of blood clots in veins by 47 percent, blood clots in arteries by 28 percent, and heart failure by 39 percent in the six months after vaccination.

“The overall message is that if you are vaccinated, your risk of developing cardiovascular disease and thromboembolic complications after COVID-19 is reduced quite dramatically,” Prieto Alhambra said. The professor concluded.

The researchers also emphasized that the protective effects of COVID-19 vaccines may wane in the long term.

For comments or feedback, please contact us at editorial@rttnews.com.

business news